#

IPO

: 450
Anthropic plans to allocate about one-third of its IPO prospectus to risk factors, according to The Wall Street Journal / Photo: Poetra.RH/Shutterstock.com
News·
Losses Exceeding $80 Billion and Rapidly Rising Costs: What the WSJ Learned from Anthropic's Prospectus
Defense tech Sensofusion began trading on the Nasdaq in early October, its IPO having been several times oversubscribed, according to the firm / Photo: LinkedIn / Sensofusion
Small Caps·
+1
·
From PDFs to drone defense: How Finland’s newest billionaire built his business
Elices disastrous debut following its IPO in Seoul has heightened doubts about the wisdom of massive investments in AI / Photo: Shutterstock.com
News·
Shares of the AI startup Elice plummeted 32% after its IPO. Why is this a bad sign for the market?
The sharp drop in the stock price of South Korean startup Elice following its IPO confirmed investors’ ongoing concerns about AI-related stocks / Photo: Shutterstock.com
Review·
Morning Highlights: AI Startup's Stock Plummets After IPO; Anthropic and Nscale Deal
Top Stories This Morning: Fears of a Crisis in Europe; Treasuries Regain Their Status as a Safe Haven
Review·
Top Stories This Morning: Fears of a Crisis in Europe; Treasuries Regain Their Status as a Safe Haven
Investment in the space industry could top $100 billion for the first time in 2026, fueled in part by SpaceX’s record-breaking IPO / Photo: rblfmr / Shutterstock.com
News·
IPO roundup: Anthropic valuation falls, SpaceX lifts space-sector investment
The company is developing RNAi-based drugs to treat thromboembolic diseases and Stargardt disease, with its lead product in early-stage trials / Photo: City Therapeutics
Small Caps·
City Therapeutics IPO: Developer of RNAi-based drugs debuts on the Nasdaq
A cooler reception for Anthropics IPO could weigh on the wider AI market, Reuters notes / Photo: PJ McDonnell / Shutterstock.com
News·
Investors weigh lower Anthropic IPO valuation after $2 trln expectations
Iambic develops cancer drugs using its AI platform / Photo: Iambic
Small Caps·
Iambic IPO: Biotech backed by Nvidia and Cathie Wood debuts on the Nasdaq
A month before its IPO, Anthropic is trying to convince investors that its massive expenses are worthwhile / Photo: Algi Febri Sugita / Shutterstock.com
News·
Anthropic's revenue surge will help its IPO, but is unlikely to save the entire AI sector, experts say
Anthropics IPO could be the largest in history, breaking SpaceXs record / Photo: Stockinq / Shutterstock.com
News·
Anthropic reported a 50% increase in revenue to $16.8 billion as it prepares for its IPO
Paul Tudor Jones told CNBC that next year could be a tough one for the stock market because of increased equity supply from big tech IPOs / Photo: Invest Like The Best
News·
Trader who predicted Black Monday plans to short U.S. stocks throughout 2027
Load more